Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries | 26 | 2022 | 787 | 2.600 |
Why?
|
| Brain Concussion | 8 | 2023 | 194 | 2.410 |
Why?
|
| Stress Disorders, Post-Traumatic | 13 | 2022 | 604 | 2.370 |
Why?
|
| Military Personnel | 8 | 2022 | 225 | 2.000 |
Why?
|
| Veterans | 16 | 2023 | 1641 | 1.660 |
Why?
|
| Brain Mapping | 12 | 2016 | 644 | 1.340 |
Why?
|
| Neuropsychological Tests | 27 | 2023 | 1178 | 1.190 |
Why?
|
| Brain | 18 | 2022 | 4113 | 0.970 |
Why?
|
| Cognition | 11 | 2023 | 968 | 0.860 |
Why?
|
| Blast Injuries | 7 | 2022 | 48 | 0.840 |
Why?
|
| Cognition Disorders | 8 | 2015 | 786 | 0.800 |
Why?
|
| Brain Injuries, Traumatic | 6 | 2022 | 367 | 0.740 |
Why?
|
| Executive Function | 4 | 2016 | 160 | 0.720 |
Why?
|
| Memory, Short-Term | 7 | 2015 | 160 | 0.680 |
Why?
|
| White Matter | 4 | 2022 | 195 | 0.590 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2021 | 7702 | 0.540 |
Why?
|
| Frontal Lobe | 8 | 2007 | 187 | 0.470 |
Why?
|
| Impulsive Behavior | 1 | 2015 | 142 | 0.470 |
Why?
|
| Neural Pathways | 3 | 2018 | 298 | 0.450 |
Why?
|
| Gyrus Cinguli | 3 | 2013 | 140 | 0.440 |
Why?
|
| Neuroimaging | 5 | 2022 | 403 | 0.410 |
Why?
|
| Theory of Mind | 1 | 2011 | 26 | 0.400 |
Why?
|
| Iraq War, 2003-2011 | 9 | 2022 | 106 | 0.380 |
Why?
|
| Afghan Campaign 2001- | 9 | 2022 | 111 | 0.380 |
Why?
|
| Head Injuries, Closed | 7 | 2007 | 45 | 0.340 |
Why?
|
| Glasgow Coma Scale | 12 | 2013 | 215 | 0.340 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2020 | 1648 | 0.320 |
Why?
|
| Brain Damage, Chronic | 4 | 2000 | 37 | 0.300 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 901 | 0.280 |
Why?
|
| Regression Analysis | 6 | 2015 | 1546 | 0.280 |
Why?
|
| Brain Injury, Chronic | 4 | 2015 | 21 | 0.250 |
Why?
|
| Neuroanatomy | 1 | 2004 | 14 | 0.240 |
Why?
|
| Memory Disorders | 4 | 2015 | 295 | 0.240 |
Why?
|
| Photic Stimulation | 3 | 2015 | 259 | 0.230 |
Why?
|
| Visual Perception | 2 | 2015 | 154 | 0.220 |
Why?
|
| Adult | 31 | 2022 | 77950 | 0.210 |
Why?
|
| Disability Evaluation | 2 | 2001 | 249 | 0.210 |
Why?
|
| Depression | 3 | 2011 | 1715 | 0.210 |
Why?
|
| Male | 48 | 2022 | 123000 | 0.210 |
Why?
|
| Humans | 60 | 2023 | 261506 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2018 | 592 | 0.200 |
Why?
|
| Analysis of Variance | 7 | 2011 | 2307 | 0.190 |
Why?
|
| Amygdala | 3 | 2013 | 127 | 0.190 |
Why?
|
| Reaction Time | 4 | 2014 | 234 | 0.190 |
Why?
|
| Cerebral Cortex | 3 | 2018 | 621 | 0.180 |
Why?
|
| Interferon-alpha | 1 | 2004 | 889 | 0.170 |
Why?
|
| Alcoholism | 1 | 2022 | 285 | 0.170 |
Why?
|
| Task Performance and Analysis | 2 | 2011 | 136 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2022 | 2803 | 0.160 |
Why?
|
| Oxygen | 5 | 2018 | 754 | 0.160 |
Why?
|
| Female | 42 | 2022 | 141928 | 0.150 |
Why?
|
| Caudate Nucleus | 2 | 2015 | 43 | 0.150 |
Why?
|
| Verbal Learning | 3 | 2011 | 84 | 0.150 |
Why?
|
| Chronic Pain | 2 | 2018 | 238 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2018 | 303 | 0.150 |
Why?
|
| Craniocerebral Trauma | 1 | 1998 | 130 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 1998 | 170 | 0.150 |
Why?
|
| Supervised Machine Learning | 1 | 2016 | 12 | 0.140 |
Why?
|
| Adolescent | 24 | 2016 | 31252 | 0.140 |
Why?
|
| War Exposure | 1 | 2015 | 8 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 471 | 0.130 |
Why?
|
| Self Report | 3 | 2015 | 756 | 0.130 |
Why?
|
| Young Adult | 10 | 2016 | 21445 | 0.130 |
Why?
|
| Connectome | 1 | 2016 | 112 | 0.120 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 38 | 0.120 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 4320 | 0.110 |
Why?
|
| Verbal Behavior | 2 | 2010 | 62 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 2013 | 102 | 0.110 |
Why?
|
| Hippocampus | 3 | 2020 | 915 | 0.110 |
Why?
|
| Corpus Callosum | 2 | 2006 | 138 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 4314 | 0.110 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 399 | 0.110 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2004 | 2527 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2013 | 980 | 0.100 |
Why?
|
| Dominance, Cerebral | 4 | 2007 | 81 | 0.100 |
Why?
|
| Case-Control Studies | 7 | 2015 | 6100 | 0.090 |
Why?
|
| Warfare | 1 | 2010 | 37 | 0.090 |
Why?
|
| Thinking | 1 | 2010 | 33 | 0.090 |
Why?
|
| Intelligence Tests | 1 | 2009 | 88 | 0.090 |
Why?
|
| Automation | 1 | 2010 | 151 | 0.090 |
Why?
|
| Social Behavior | 1 | 2011 | 306 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2010 | 106 | 0.090 |
Why?
|
| Functional Laterality | 4 | 2010 | 316 | 0.090 |
Why?
|
| Cognitive Dysfunction | 1 | 2014 | 333 | 0.090 |
Why?
|
| Education | 1 | 2009 | 112 | 0.080 |
Why?
|
| Middle Aged | 14 | 2019 | 86204 | 0.080 |
Why?
|
| Patient Selection | 1 | 2016 | 2055 | 0.080 |
Why?
|
| Self Concept | 1 | 2010 | 211 | 0.080 |
Why?
|
| Child | 16 | 2011 | 29154 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 290 | 0.080 |
Why?
|
| Discrimination Learning | 1 | 2007 | 30 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 14889 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2010 | 445 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2007 | 64 | 0.070 |
Why?
|
| Temporal Lobe | 2 | 2007 | 192 | 0.070 |
Why?
|
| Arousal | 1 | 2007 | 120 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2010 | 6009 | 0.070 |
Why?
|
| Gambling | 1 | 2006 | 22 | 0.070 |
Why?
|
| Trauma Severity Indices | 3 | 2013 | 98 | 0.070 |
Why?
|
| Glioblastoma | 1 | 1996 | 1797 | 0.070 |
Why?
|
| Glioma | 1 | 1996 | 1963 | 0.060 |
Why?
|
| Anisotropy | 3 | 2010 | 181 | 0.060 |
Why?
|
| Reference Values | 4 | 2007 | 1099 | 0.060 |
Why?
|
| Risk Factors | 1 | 2021 | 17523 | 0.060 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2004 | 48 | 0.060 |
Why?
|
| Mental Disorders | 1 | 1990 | 862 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2003 | 229 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 1996 | 4849 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2023 | 12873 | 0.050 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2019 | 9244 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1582 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 1945 | 0.050 |
Why?
|
| Gray Matter | 1 | 2020 | 63 | 0.050 |
Why?
|
| Mental Status Schedule | 1 | 2000 | 60 | 0.050 |
Why?
|
| Awareness | 1 | 2001 | 126 | 0.050 |
Why?
|
| Interferon Type I | 2 | 1991 | 250 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 764 | 0.040 |
Why?
|
| Atrophy | 3 | 2007 | 261 | 0.040 |
Why?
|
| Mental Recall | 1 | 2000 | 171 | 0.040 |
Why?
|
| Psychometrics | 2 | 2000 | 937 | 0.040 |
Why?
|
| Decision Making | 1 | 2006 | 1287 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 2315 | 0.040 |
Why?
|
| Patient Dropouts | 1 | 1998 | 88 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2019 | 1819 | 0.040 |
Why?
|
| Concept Formation | 1 | 1997 | 32 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 1021 | 0.040 |
Why?
|
| Problem Solving | 1 | 1997 | 85 | 0.040 |
Why?
|
| Back Injuries | 1 | 2016 | 7 | 0.040 |
Why?
|
| Arm Injuries | 1 | 2016 | 20 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2016 | 71 | 0.030 |
Why?
|
| Leg Injuries | 1 | 2016 | 31 | 0.030 |
Why?
|
| United States | 3 | 2022 | 15433 | 0.030 |
Why?
|
| Models, Neurological | 1 | 1997 | 225 | 0.030 |
Why?
|
| Child Development | 1 | 1997 | 255 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 953 | 0.030 |
Why?
|
| Neurologic Examination | 3 | 2004 | 245 | 0.030 |
Why?
|
| Acute Disease | 1 | 1998 | 2422 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 1996 | 383 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 134 | 0.030 |
Why?
|
| Antisocial Personality Disorder | 1 | 1992 | 62 | 0.030 |
Why?
|
| Neurocognitive Disorders | 1 | 1992 | 69 | 0.030 |
Why?
|
| Child, Preschool | 6 | 2010 | 16273 | 0.030 |
Why?
|
| Coma | 1 | 1991 | 61 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1996 | 2231 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1991 | 66 | 0.020 |
Why?
|
| Peroxides | 1 | 2010 | 12 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1992 | 203 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 26 | 0.020 |
Why?
|
| Internal Capsule | 1 | 2010 | 40 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 57 | 0.020 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1990 | 82 | 0.020 |
Why?
|
| Time | 1 | 2010 | 178 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 122 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 2004 | 552 | 0.020 |
Why?
|
| Interferons | 1 | 1990 | 291 | 0.020 |
Why?
|
| Urea | 1 | 2010 | 290 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 3890 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 690 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 671 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 2352 | 0.020 |
Why?
|
| Neoplasms | 2 | 1991 | 15193 | 0.020 |
Why?
|
| Adenoma | 1 | 1992 | 716 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2007 | 103 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2007 | 66 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 1991 | 441 | 0.020 |
Why?
|
| Attention | 2 | 2000 | 281 | 0.020 |
Why?
|
| Glasgow Outcome Scale | 1 | 2006 | 47 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1990 | 842 | 0.020 |
Why?
|
| Age Factors | 2 | 2010 | 5377 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 1225 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 4532 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2006 | 341 | 0.010 |
Why?
|
| Social Adjustment | 1 | 2004 | 114 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 70117 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 418 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 1085 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 482 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 756 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 703 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1990 | 1824 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 305 | 0.010 |
Why?
|
| Software | 1 | 2010 | 1321 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 21713 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2004 | 32848 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 4892 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2015 | 37905 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2000 | 35 | 0.010 |
Why?
|
| Dichotic Listening Tests | 1 | 1999 | 5 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2000 | 237 | 0.010 |
Why?
|
| Rehabilitation Centers | 1 | 2000 | 83 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 59536 | 0.010 |
Why?
|
| Volition | 1 | 1997 | 11 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 1323 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2000 | 297 | 0.010 |
Why?
|
| Communication | 1 | 2004 | 876 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1992 | 5542 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 13310 | 0.010 |
Why?
|
| Delusions | 1 | 1992 | 21 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1991 | 425 | 0.010 |
Why?
|
| Craniotomy | 1 | 1992 | 304 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1997 | 4298 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1990 | 14289 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1991 | 898 | 0.000 |
Why?
|
| Lymphoma | 1 | 1991 | 1467 | 0.000 |
Why?
|
| Survival Rate | 1 | 1991 | 12221 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1991 | 7551 | 0.000 |
Why?
|
| Melanoma | 1 | 1991 | 5317 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1991 | 11538 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1991 | 15694 | 0.000 |
Why?
|